Abstract representation of Moderna's diversified mRNA pipeline targeting Japan’s infectious and rare diseases.
As mRNA biotechnology matures, few firms have demonstrated a shift as dynamic as Moderna. Widely recognised […]
Illustration showing Japan's pharmaceutical market decline with red arrow, pills, and bar graph.
In the mid-1990s, Japan was not merely participating in the global pharmaceutical industry—it was shaping it. […]
  Just now, AstraZeneca is making headlines with a $5.3 billion AI research partnership with China’s […]
: A bustling exhibition displaying the latest in IVD technology at the JACLaS Tradeshow. An official JACKLaS image.
Just before BioJapan 2025 takes over Pacifico Yokohama (Oct 8–10), another major event for diagnostics, JACLaS […]
Japan’s IVD sector remains highly structured and closely governed, benefiting from a mature healthcare infrastructure and […]
Abstract illustration representing Japan’s SaMD commercialization ecosystem.
Japan is the fourth-largest global medical device market, with its healthcare system actively integrating digital tools […]
Timeline collage of vintage lab tools, 1990s computer, and glowing AI brain in a modern Japanese lab.
From Automation to Inflexion: AI’s Historical Trajectory in Pharma The pharmaceutical industry began its journey with […]
Speaker presenting at the launch event of TOBU on-demand biobank in Japan.
Some of Japan’s most forward-thinking minds gathered to scrutinise Japan’s biobank conundrum at Shonan iPark. In […]
Navigating Japan’s life sciences sector successfully hinges on more than just excellent science or a meticulously […]